Podcast
Thinking Thoracic
Hosted by thinkingthoracic · EN
The Society of Thoracic Surgeon Thinking Thoracic podcast dives deep into the latest advancements and breakthroughs shaping the future of thoracic surgery. The podcast series is hosted by a dedicated team of STS member surgeons, including Dr. Hari Keshava, Dr. Jeff Yang, Dr. Erin Gillaspie, and Dr. Jane Yanagawa.
.
14episodes
Episodes
Newest firstAll episodes
#23, S2 The Year's Most Important Thoracic Oncology Papers, Part 2
2w ago00:23:03Tap to summarizeIn Part 2 of Thinking Thoracic's annual review of the year's most influential thoracic oncology research, Drs. Jeff Yang and Linda Martin examine practice-changing studies in perioperative care, lung cancer treatment, and multidisciplinary cancer management. The discussion covers emerging evidence on cryoanalgesia, preoperative fasting, targeted therapies for EGFR-mutated lung cancer, and other key clinical trials and consensus recommendations that are influencing patient care today.
Transcribe →#22, S2 The Year's Most Important Thoracic Oncology Papers, Part 1
2w ago00:47:30Tap to summarizeIn Part 1 of this special Thinking Thoracic episode, Dr. Jeff Yang welcomes Dr. Linda Martin for a discussion of groundbreaking research spanning immunotherapy, lung cancer epidemiology, and screening. Together, they explore emerging organ-preserving strategies for mismatch repair-deficient cancers, the growing population of patients with lung cancer who have never smoked, and new data highlighting opportunities to improve screening eligibility and uptake. Hear expert analysis of the studies shaping the future of thoracic oncology and what these findings mean for surgeons and patients alike.
Transcribe →Best of Lung Cancer Science 2026 -- European Lung Cancer Congress (ELCC)
3w ago00:38:45Tap to summarizeHost Dr. Erin Gillaspie is back with a new season of the popular Best of Lung Cancer Science video podcast series. In this episode, featuring Dr. Jonathan Spicer, they break down key takeaways from the European Lung Cancer Congress, including evolving surgical approaches and how biology, AI, and real-world data are reshaping lung cancer care.
Transcribe →#21, S2 Breaking the Stigma: Closing Gaps in Lung Cancer Care for Women
May 2600:46:33Tap to summarizeIn recognition of National Women’s Health Month, this episode of Thinking Thoracic analyzes the evolving landscape of female-specific lung cancer care. Co-hosts Dr. Erin Gillaspie and Dr. Jane Yanagawa sit down with guest Dr. Leah Backhus to discuss a critical disparity: lung cancer is the leading cause of cancer death among women, yet screening practices remain inequitable. This timely episode moves beyond smoking history to examine the rise of lung cancer in never-smokers and Asian women. From the "stigma" of a diagnosis to innovative solutions like co-scheduling screenings with mammograms, providing a powerful call to action for more inclusive, biomarker-driven care.
Transcribe →#20, S2 Advancing ERAS and the Evolution of Minimally Invasive Thoracic Surgery
Apr 2100:35:48Tap to summarizeIn this episode of Thinking Thoracic, podcast hosts Hari Keshava, MD, and Erin Gillaspie, MD, talk with René Petersen, MD, of Copenhagen University Hospital, about the latest developments in Enhanced Recovery After Surgery (ERAS) protocols. As a longtime leader and pioneer in the field, Dr. Petersen shares insights from his extensive experience advancing recovery practices. The conversation covers the broader evolution of minimally invasive thoracic surgery, including video-assisted approaches, and how these developments inform patient selection for tubeless procedures.
Transcribe →#19, S2 Breathing New Life into Emphysema Care
Mar 3000:40:42Tap to summarizen this episode of Thinking Thoracic, podcast hosts Hari Keshave, MD, and Erin Gillaspie, MD, talk with J. W. Awori Hayanga, MD, West Virginia University Medicine, about his recent study published in The Annals of Thoracic Surgery on surgical interventions for end-stage emphysema. The conversation highlights symptom burden, a multidisciplinary approach to treatment, and the latest data on lung volume reduction surgery. Article references: Hayanga JWA, Luo X, Reddy S, Mehaffey JH, Rothenberg P, Chauhan D, Rajjoub H, Mascio C, Baker N, Badhwar V, Lamb J, Toker A. Endobronchial Valve Therapy vs Lung Volume Reduction Surgery in the United States. Ann Thorac Surg. 2025 Nov;120(5):917-925. doi: 10.1016/j.athoracsur.2025.06.053. Epub 2025 Jul 19. PMID: 40691922; PMCID: PMC12542816 Hayanga JWA, Voppuru S, Bham N, Hansen A, Mehaffey JH, Rajjoub H, Reddy S, Badhwar V, Lamb J. Higher Costs and Lower Reimbursement of Endobronchial Valve Therapy vs Lung Volume Reduction Surgery in the United States. Ann Thorac Surg. 2026 Jan;121(1):174-180. doi: 10.1016/j.athoracsur.2025.09.033. Epub 2025 Nov 6. PMID: 41205846.
Transcribe →#18, S2 New Advances in Thoracic Surgery at STS 2026
Mar 900:38:45Tap to summarizeIn the season two premiere episode of Thinking Thoracic, cohosts Drs. Erin Gillaspie, Hari Keshava, Jeff Yang, and Jane Yanagawa review the latest thoracic surgery research presented at the 2026 STS Annual Meeting in New Orleans.
Transcribe →Best of Lung Cancer Science - World Conference on Lung Cancer (WCLC)
Feb 1800:43:24Tap to summarizeLeah Backhus, MD, joins Dr. Gillaspie to explore key takeaways from WCLC, including how precision data, surgical restraint, and breakthrough immunotherapy are transforming care.
Transcribe →Best of Lung Cancer Science - European Lung Cancer Congress (ELCC)
Feb 1800:41:04Tap to summarizeIn this episode, Dr. Gillaspie speaks with Paula Ugalde, MD, to examine findings from ELCC, including restaging in the neoadjuvant era, redefining resectability, AI in multidisciplinary precision, and the de-escalation debate.
Transcribe →Best of Lung Cancer Science - European Society for Medical Oncology (ESMO)
Feb 1801:11:12Tap to summarizeJessica Donington, MD, and Christine Bestvina, MD, join Dr. Gillaspie to unpack key lung cancer advances from ESMO, including adjuvant ALK inhibition (ALINA, ELEVATE), perioperative immunotherapy (KEYNOTE-671), and the expanding neoadjuvant space in borderline resectable disease.
Transcribe →